ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Treatment of uncomplicated non-falciparum malaria

Treatment of uncomplicated non-falciparum malaria
  Drug Adult dosing Pediatric dosing Pregnancy*

P. vivax

P. ovale

(chloroquine-sensitive)

Chloroquine

OR

Hydroxy-chloroquine

PLUS

PrimaquineΔ

Chloroquine 600 mg base (=1000 mg salt) orally immediately, followed by 300 mg base (=500 mg salt) orally at 6, 24, and 48 hours. Total dose: 1500 mg base (=2500 mg salt)

Hydroxychloroquine 620 mg base (=800 mg salt) orally immediately, followed by 310 mg base (=400 mg salt) orally at 6, 24, and 48 hours. Total dose: 1550 mg base (=2000 mg salt)

PrimaquineΔ 30 mg base orally once daily for 14 days

Chloroquine 10 mg base/kg orally immediately, followed by 5 mg base/kg orally at 6, 24, and 48 hours. Total dose: 25 mg base/kg

Hydroxychloroquine 10 mg base/kg orally immediately, followed by 5 mg base/kg orally at 6, 24, and 48 hours. Total dose: 25 mg base/kg

PrimaquineΔ 30 mg base orally once daily for 14 days

Chloroquine

OR

Hydroxy-chloroquine

Chloroquine-resistant P. vivax§

(Papua New Guinea and Indonesia)

A. Mefloquine

OR

Atovaquone-proguanil (Malarone)

PLUS

PrimaquineΔ

A. Mefloquine 648 mg base (=750 mg salt) orally as initial dose, followed by 456 mg base (=500 mg salt) orally given 6 to 12 hours after initial dose (total dose = 1250 mg salt)

Atovaquone-proguanil (Malarone) Adult tab = 250 mg atovaquone / 100 mg proguanil.

4 adult tabs orally once daily for 3 days

Primaquine (as above)

A. Mefloquine 13.7 mg base/kg (=15 mg salt/kg) orally as initial dose, followed by 9.1 mg base/kg (=10 mg salt//kg) orally given 6 to 12 hours after initial dose (total dose = 25 mg salt/kg)

Atovaquone-proguanil (Malarone) Peds tab=62.5 mg atovaquone/ 25 mg proguanil.

All doses administered orally once daily for 3 days: 5 to 8 kg: 2 peds tabs; 9 to 10 kg: 3 peds tabs; 11 to 20 kg: 1 adult tab; 21 to 30 kg: 2 adult tabs; 31 to 40 kg: 3 adult tabs; >40kg: 4 adult tabs

Primaquine (as above)
A. Mefloquine (only)

B. Quinine

PLUS one of the following:

Doxycycline

Tetracycline

PLUS

PrimaquineΔ

B. Quinine¥ 542 mg base (=650 mg salt) orally three times daily x 3 to 7 days

Doxycycline 100 mg orally twice daily x 7 days

Tetracycline 250 mg orally four times daily x 7 days

Primaquine (as above)

B. Quinine¥ 8.3 mg base/kg (=10 mg salt/kg) orally three times daily x 3 to 7 days

Doxycycline 2.2 mg/kg orally twice daily x 7 days

Tetracycline 25 mg/kg/day orally divided four times daily x 7 days

Primaquine (as above)
B. Quinine (only)

P. malariae

P. knowlesii

Chloroquine

OR

Hydroxy-chloroquine

Chloroquine (as above)

Hydroxychloroquine (as above)

Chloroquine (as above)

Hydroxychloroquine (as above)

Chloroquine

OR

Hydroxy-chloroquine
* Dosing as for adults. Primaquine, doxycycline, and tetracycle are contraindicated in pregnancy.
¶ Hydroxychloroquine is a second line alternative to chloroquine.
Δ Primaquine is used to prevent P. vivax and P. ovale relapse by eradicating hypnozoite forms that may remain dormant in the liver. Because primaquine can cause hemolytic anemia in persons with G6PD deficiency, screening for G6PD deficiency is required prior to starting treatment with primaquine. Primaquine is contraindicated in pregnancy given uncertain neonatal G6PD status.
To prevent relapse of P. vivax, primaquine should be dosed 30 mg/day for 14 days. To prevent relapse of P. ovale, primaquine should be dosed 15 mg base/day for 14 days. Primaquine therapy should begin on the same day of treatment with chloroquine.
§ For treatment of uncomplicated malaria due to chloroquine-resistant P. vivax, there are two options (A or B) that are equally recommended. Individuals with P. vivax infection acquired outside of Papua New Guinea or Indonesia should be started on chloroquine; if the patient does not respond, the treatment should be changed to a chloroquine-resistant P. vivax regimen.
¥ For infections acquired in Southeast Asia, quinine treatment should continue for seven days. For infections acquired in Africa and South America, quinine treatment should continue for three days. In the United States, quinine is encapsulated in a 324 mg dose; therefore, for adult dosing, two capsules are sufficient. For pediatric dosing, if non-capsule forms are not available, atovaquone-proguanil or mefloquine may be used. Dosing for atovaquone-proguanil is outlined separately (see "Treatment of malaria").
‡ Doxycycline and tetracycline are not indicated for use in children <8 years. For children <8 years with chloroquine-resistant P. vivax, quinine (given alone for seven days) or mefloquine may be used. If these options are not available or not tolerated and if treatment benefits outweigh the risks, doxycycline or tetracycline may be given to children <8 years.
Graphic 67642 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟